Bibliothèque

[The perioperative safety analysis of conversion therapy for liver cancer: a single-center retrospective study].

To investigate the perioperative safety of patients with hepatocellular carcinoma (HCC) undergoing conversion therapy followed by sequential surgical resection. This study was designed as a retrospe…

Thérapies de Conversion

Wei, Z. W., & Cai, J. Q. (2026). [The perioperative safety analysis of conversion therapy for liver cancer: a single-center retrospective study].. Zhonghua Wai Ke Za Zhi, 64(4), 330-336. https://doi.org/10.3760/cma.j.cn112139-20250815-00404

01/04/2026 Lire →

Surgery-centered integrated strategies for personalized hepatocellular carcinoma care.

Hepatocellular carcinoma (HCC) remains a major global health burden characterized by late-stage diagnosis and high postoperative recurrence rates. This review presents a surgery-centered precision man…

Thérapies de Conversion

Cui, Y., Du, Z., Xu, J., Gu, L., Du, J., Wang, M., & Yang, T. (2026). Surgery-centered integrated strategies for personalized hepatocellular carcinoma care.. Cancer Biol Med. https://doi.org/10.20892/j.issn.2095-3941.2026.0045

30/03/2026 Lire →

Gemcitabine-cisplatin plus durvalumab in advanced intrahepatic cholangiocarcinoma: effectiveness outcomes and characterization of the tumor microenvironment.

BACKGROUND/AIMS: Most patients with intrahepatic cholangiocarcinoma (ICC) present with advanced, unresectable disease. Although gemcitabine-cisplatin (GC) plus durvalumab improves outcomes, its real-w…

Thérapies de Conversion

Xu, J., Ji, Y., Feng, M., Zhang, Z., & Yu, D. (2026). Gemcitabine-cisplatin plus durvalumab in advanced intrahepatic cholangiocarcinoma: effectiveness outcomes and characterization of the tumor microenvironment.. Hepatol Int. https://doi.org/10.1007/s12072-026-11070-y

24/03/2026 Lire →

Efficacy and Safety of Conversion Surgery Versus Non-Surgical Treatment for Initially Unresectable Esophageal Cancer: A Systematic Review and Meta-Analysis.

Thérapies de Conversion

Chen, L., Zhao, J., & Luo, X. (2026). Efficacy and Safety of Conversion Surgery Versus Non-Surgical Treatment for Initially Unresectable Esophageal Cancer: A Systematic Review and Meta-Analysis.. J Gastrointest Cancer, 57(1). https://doi.org/10.1007/s12029-026-01440-y

23/03/2026 Lire →

[Recent advances in hepatic arterial infusion chemotherapy for conversion therapy of hepatocellular carcinoma].

Hepatocellular carcinoma(HCC) is one of the common malignant tumors in China. Most patients are diagnosed at an intermediate or advanced stage, thereby losing the opportunity for curative treatment. T…

Thérapies de Conversion

Chen, M. S., & Xiao, R. (2026). [Recent advances in hepatic arterial infusion chemotherapy for conversion therapy of hepatocellular carcinoma].. Zhonghua Yi Xue Za Zhi, 106(10), 891-896. https://doi.org/10.3760/cma.j.cn112137-20251021-02699

17/03/2026 Lire →

[Sequential surgery following conversion therapy based on the combination of immune checkpoint inhibitors and antiangiogenic targeted drugs alters the treatment landscape and outcomes for advanced hepatocellular carcinoma].

Hepatocellular carcinoma (HCC) often presents insidiously, and the majority of patients are diagnosed at an advanced stage, missing the opportunity for curative surgery. In recent years, breakthrough …

Thérapies de Conversion

Tang, H. W., Jiang, H. X., Cao, Y. B., & Lu, S. C. (2026). [Sequential surgery following conversion therapy based on the combination of immune checkpoint inhibitors and antiangiogenic targeted drugs alters the treatment landscape and outcomes for advanced hepatocellular carcinoma].. Zhonghua Yi Xue Za Zhi, 106(10), 885-890. https://doi.org/10.3760/cma.j.cn112137-20251116-02982

17/03/2026 Lire →

LGBTQ+ Ayahuasca Retreat Experience is Associated with Benefits to Mental Health, Quality of Life, and Spiritual Well-Being: A Prospective, Naturalistic Study.

Sexual and gender minority (SGM) individuals experience disproportionately high rates of depression, anxiety, trauma, and discrimination, yet remain underrepresented in psychedelic research. This pros…

Spiritualité Saine et Résilience Thérapies de Conversion

Lowe, M. X., Darby, Q. A., Kalcheff-Korn, S., & Jackson, H. (2026). LGBTQ+ Ayahuasca Retreat Experience is Associated with Benefits to Mental Health, Quality of Life, and Spiritual Well-Being: A Prospective, Naturalistic Study.. J Psychoactive Drugs, 1-12. https://doi.org/10.1080/02791072.2026.2644858

13/03/2026 Lire →

Optimal duration of adjuvant targeted-immunotherapy in patients with initially unresectable hepatocellular carcinoma with portal vein tumor thrombus following successful conversion therapy.

BACKGROUND: The management of initially unresectable hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) has been revolutionized by conversion therapy combining locoregional and syst…

Thérapies de Conversion

Wang, L., Feng, J. K., Zhou, B., Liu, Z. H., Gong, L., Yan, M. L., Zhao, H. T., Jiang, Y. B., Shi, J., Guo, W. X., Yuan, Y., Lu, C. D., & Cheng, S. Q. (2026). Optimal duration of adjuvant targeted-immunotherapy in patients with initially unresectable hepatocellular carcinoma with portal vein tumor thrombus following successful conversion therapy.. Oncologist, 31(4). https://doi.org/10.1093/oncolo/oyag054

09/03/2026 Lire →

Expert consensus on the use of immune checkpoint inhibitors in the liver transplant setting: Guidance from the Liver Transplant Committee of the Italian Association for the Study of the Liver (AISF).

Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape for advanced hepatocellular carcinoma, increasing opportunities for downstaging and conversion to liver transplantation (LT…

Thérapies de Conversion

Ponziani, F. R., Giannelli, V., Marrone, G., Martini, S., Morelli, M. C., Pagano, D., Baroni, G. S., Germani, G., Burra, P., & Toniutto, P. (2026). Expert consensus on the use of immune checkpoint inhibitors in the liver transplant setting: Guidance from the Liver Transplant Committee of the Italian Association for the Study of the Liver (AISF).. Am J Transplant. https://doi.org/10.1016/j.ajt.2026.02.024

03/03/2026 Lire →

Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab.

BACKGROUND: The current Barcelona Clinic Liver Cancer (BCLC) classification recommends systemic treatment with atezolizumab and bevacizumab as the first-line therapy for advanced hepatocellular carcin…

Thérapies de Conversion

Popovic, P., Kalamutova, A., Djokic, M., Cuderman, A., Boltezar, G., & Trotovsek, B. (2026). Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab.. Radiol Oncol, 60(1), 40-48. https://doi.org/10.2478/raon-2026-0015

01/03/2026 Lire →

Preoperative chemotherapy in colorectal peritoneal metastatic disease - a real-world observational cohort study.

OBJECTIVES: The effects of preoperative chemotherapy have been poorly studied in colorectal cancer with peritoneal metastases (CRC-PM). This study evaluated preoperative chemotherapy from the first mu…

Thérapies de Conversion

Cashin, P. H., Frühling, P., Grönlund, P., Graf, W., Nygren, P., & Ghanipour, L. (2026). Preoperative chemotherapy in colorectal peritoneal metastatic disease - a real-world observational cohort study.. Pleura Peritoneum, 11(1), 1-10. https://doi.org/10.1515/pp-2025-0035

01/03/2026 Lire →

A novel triple-modality approach overcoming prohibitive hepatopulmonary shunt (HPS): Enabling yttrium-90 selective internal radiation therapy (Y90-SIRT) and subsequent curative resection in massive hepatocellular carcinoma (HCC).

Elevated hepatopulmonary shunt exceeding 20% is a strict contraindication for Y90-SIRT due to the risk of fatal radiation pneumonitis, posing a significant clinical challenge in the management of such…

Thérapies de Conversion

Luo, Y., & Lin, Y. (2026). A novel triple-modality approach overcoming prohibitive hepatopulmonary shunt (HPS): Enabling yttrium-90 selective internal radiation therapy (Y90-SIRT) and subsequent curative resection in massive hepatocellular carcinoma (HCC).. Radiol Case Rep, 21(3), 1099-1103. https://doi.org/10.1016/j.radcr.2025.11.007

01/03/2026 Lire →